Caffeine
4 sources
🧬 Receptor activity
| Target | Action | Affinity | Source | |
|---|---|---|---|---|
| Adenosine receptor A1 (ADORA1) | Antagonist | 4.97 Ki | DRUGCENTRAL | TargetAdenosine receptor A1 (ADORA1) ActionAntagonist Affinity4.97 Ki SourceDRUGCENTRAL |
| Adenosine receptor A2a (ADORA2A) | Antagonist | 5.61 Ki | DRUGCENTRAL | TargetAdenosine receptor A2a (ADORA2A) ActionAntagonist Affinity5.61 Ki SourceDRUGCENTRAL |
| Adenosine receptor A2b (ADORA2B) | Antagonist | 4.77 Ki | DRUGCENTRAL | TargetAdenosine receptor A2b (ADORA2B) ActionAntagonist Affinity4.77 Ki SourceDRUGCENTRAL |
| Adenosine receptor A3 (ADORA3) | Antagonist | 4.33 Ki | DRUGCENTRAL | TargetAdenosine receptor A3 (ADORA3) ActionAntagonist Affinity4.33 Ki SourceDRUGCENTRAL |
| Acetylcholinesterase (ACHE) | — | 5.14 IC50 | DRUGCENTRAL | TargetAcetylcholinesterase (ACHE) Action— Affinity5.14 IC50 SourceDRUGCENTRAL |
| Adenosine A2 receptor (Adora2b) | — | 4.57 Ki | DRUGCENTRAL | TargetAdenosine A2 receptor (Adora2b) Action— Affinity4.57 Ki SourceDRUGCENTRAL |
| Adenosine A2a receptor (ADORA2A) | — | 4.1 Ki | DRUGCENTRAL | TargetAdenosine A2a receptor (ADORA2A) Action— Affinity4.1 Ki SourceDRUGCENTRAL |
| Adenosine receptor (Adora1) | — | 4.22 Ki | DRUGCENTRAL | TargetAdenosine receptor (Adora1) Action— Affinity4.22 Ki SourceDRUGCENTRAL |
| Adenosine receptor A1 (Adora1) | — | 4.77 Ki | DRUGCENTRAL | TargetAdenosine receptor A1 (Adora1) Action— Affinity4.77 Ki SourceDRUGCENTRAL |
| Adenosine receptor A2a (Adora2a) | — | 5.03 Ki | DRUGCENTRAL | TargetAdenosine receptor A2a (Adora2a) Action— Affinity5.03 Ki SourceDRUGCENTRAL |
| Glycogen phosphorylase, muscle form (PYGM) | — | 4.13 IC50 | DRUGCENTRAL | TargetGlycogen phosphorylase, muscle form (PYGM) Action— Affinity4.13 IC50 SourceDRUGCENTRAL |
| Guanine deaminase (GDA) | — | 4.99 Ki | DRUGCENTRAL | TargetGuanine deaminase (GDA) Action— Affinity4.99 Ki SourceDRUGCENTRAL |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform (PIK3CD) | — | 4.12 IC50 | DRUGCENTRAL | TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform (PIK3CD) Action— Affinity4.12 IC50 SourceDRUGCENTRAL |
| Potassium voltage-gated channel subfamily H member 2 (KCNH2) | — | 5.31 IC50 | DRUGCENTRAL | TargetPotassium voltage-gated channel subfamily H member 2 (KCNH2) Action— Affinity5.31 IC50 SourceDRUGCENTRAL |
External links
PubChem 2519 ↗CAS 1958-08-2 ↗CAS 58-08-2 ↗KEGG C07481 ↗ChEBI CHEBI:27732 ↗ChEMBL CHEMBL113 ↗KEGG D00528 ↗DrugBank DB00201 ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗ChemSpider ↗ChEBI/ChEMBL ↗ChEBI/ChEMBL ↗Guide to Pharmacology ↗NIH ↗NIH ↗NIH ↗NIH ↗DrugBank ↗ChEBI/ChEMBL ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗CAS 114303-55-8 ↗CAS 202282-98-2 ↗CAS 51168-26-4 ↗CAS 5743-12-4 ↗CAS 72238-85-8 ↗CAS 78072-66-9 ↗CAS 95789-13-2 ↗PsychonautWiki ↗Erowid ↗Experience reports (PiHKAL) ↗Experience reports (TiHKAL) ↗
Source: DrugCentral — Caffeine ↗
Fact-sheets from PsychonautWiki. Harm-reduction reference only — not medical advice.